Lantheus Holdings, Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Lantheus Holdings, Inc. (LNTH) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $500.00 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-07-28.
Discontinued › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2021-07-28
- Lantheus Holdings, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2021-06-30 was $500.00K.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month |
|---|---|---|
| 2021-06-30 | $500.00K 10-Q · filed 2021-07-28 | $500.00K 10-Q · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |